The molecular control of angiogenesis (Q34790019)

4 August 2017

1 reference

title

The molecular control of angiogenesis (English)

1 reference

4 August 2017

1 reference

Oliver Distler

1

1 reference

4 August 2017

Michel Neidhart

series ordinal

2

1 reference

4 August 2017

Renate E Gay

series ordinal

3

1 reference

4 August 2017

Steffen Gay

series ordinal

4

1 reference

4 August 2017

publication date

1 January 2002

1 reference

International Reviews of Immunology

4 August 2017

published in

1 reference

4 August 2017

volume

21

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

33-49

1 reference

Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

The role of angiogenesis in rheumatoid arthritis: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Systemic sclerosis. A vascular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Current biology of VEGF-B and VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Vascular endothelial growth factor C induces angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Transforming growth factor-beta inhibits endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Secreted cathepsin L generates endostatin from collagen XVIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Anticancer drug targets: approaching angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180210415

21 January 2018

Identifiers

DOI

10.1080/08830180210415

1 reference

4 August 2017

1 reference